Bellerophon Therapeutics, Inc.

BLPHDelisted Dec 27, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001600132

SEC filings (opens in a new tab)

Bellerophon Therapeutics, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Oct 16, 2023; 22 institutions reported holding it in 13F filings for Q3 2023, worth $506.6K in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding Bellerophon Therapeutics, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of BLPH: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Q1 2022	Change
Holders	22	22	0
Shares	1.23M	1.14M	−97.0K (−7.9%)
Value	$3.82M	$2.68M	−$1.14M (−29.9%)

New holders (1)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to BLPH in Q1 2022
Institution	Shares	Value	% of portfolio
Citigroup Inc	86	$0	0.00%

Sold out (1)

Institutions that held Bellerophon Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of BLPH in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Two Sigma Securities, LLC	11,161	$35.0K